Integrated genomic characterization of endometrial carcinoma
about
The Role of PARP Inhibitors in the Treatment of Gynecologic MalignanciesEstrogen receptor alpha gene amplification in breast cancer: 25 years of debateNaturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsHomologous-recombination-deficient tumours are dependent on Polθ-mediated repairMajor clinical research advances in gynecologic cancer in 2013Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome AtlasThe Cancer Genome Atlas Pan-Cancer analysis projectMolecular profiles to biology and pathways: a systems biology approachCurrent Issues in the Diagnosis and Treatment of Endometrial CarcinomaImmunotherapy: New Strategies for the Treatment of Gynecologic MalignanciesHigh Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerMEK and PI3K inhibition in solid tumors: rationale and evidence to dateMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsTranslational progress on tumor biomarkersMEF2 transcription factors: developmental regulators and emerging cancer genesNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?Patterns of Chromosomal Aberrations in Solid TumorsReverse phase protein arrays in signaling pathways: a data integration perspectiveMediator kinase module and human tumorigenesisFibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsDNA polymerase ε and its roles in genome stabilityReplicative DNA polymerase mutations in cancerFrom human genome to cancer genome: the first decadeEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Mutational signatures: the patterns of somatic mutations hidden in cancer genomesCancer stem cell division: when the rules of asymmetry are brokenThe estrogen receptor joins other cancer biomarkers as a predictor of outcomePast, present, and future of hormonal therapy in recurrent endometrial cancerEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsHijacked in cancer: the KMT2 (MLL) family of methyltransferasesEmerging patterns of somatic mutations in cancerAn Immunohistochemical Algorithm for Ovarian Carcinoma Typing.SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionSystems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional MutagenesisThe `dnet’ approach promotes emerging research on cancer patient survivalCrystal Structure of Yeast DNA Polymerase ε Catalytic DomainStructural basis for processive DNA synthesis by yeast DNA polymerase ɛActivating ESR1 mutations in hormone-resistant metastatic breast cancer.Therapeutic targeting of cancers with loss of PTEN function.
P2860
Q21129302-ED393E65-8EE8-434A-ADA1-56511022D08DQ24273274-1CC36A01-90CA-4257-BD51-42B10EF46489Q24305218-477C5A7C-9CF9-440F-9DEB-F6909058B510Q24317107-2A077843-7FBE-4B6A-9F61-157846B7C555Q24562146-FBCA20FA-9C10-4F32-904B-CE9F9CA16372Q24595911-8B959856-4B9B-4355-B466-73CE622785E1Q24606808-2A29360F-14AA-4FF1-B98B-914CD8224EFBQ26745657-FAA1B89C-99E5-4BD3-8844-DBE355E6FD73Q26768659-F2E3F8D9-7264-43EA-A114-BB9E4C2E33CFQ26770607-20D7EBD9-4914-4C3B-A8D4-0C08AC1E25C5Q26774902-0A881A1B-2B31-4A36-A1A6-7193BE8A6AD5Q26775573-E1009B0D-ACE0-48B5-A17E-DAB53F15B2D8Q26776098-E26E35C2-31CC-4E8C-9B16-ED186612D601Q26777676-5CB84DB2-CF2F-4E0A-BE82-396B47A7A29DQ26778515-B5E82701-6DA8-45CC-9A83-CEF3EB78A1CAQ26781271-F5B8EF2C-F817-4D8C-8D33-ED27273DF81DQ26786127-2B808BD1-5DE6-457A-B8F4-437E842D5455Q26799716-74418DB0-7902-4F41-9F2C-8073DA8644F9Q26800203-8722165A-2F35-483A-B137-1E39A3987434Q26801718-BFB2AE98-4AAF-4806-9788-0D531A0CCBF1Q26822699-D3ED1CA4-1A73-44DA-AC69-37AD9C85765EQ26825747-BD0BE9CB-4BDD-4AA3-8361-2EA5A8A90B87Q26827640-643D454B-A019-4DAA-865B-5AF24C43FCCDQ26827810-EBA01C09-8A28-4BB9-BE01-8C8CEEC52DF2Q26850125-D55E47D8-3CDE-4223-B74F-01F6D5640C19Q26851679-5068EEF2-D713-43E9-88FF-9660047B9338Q26865554-207193C2-5F34-400B-BC2F-338F9D595459Q26993208-11037073-3BFB-4F39-BF69-6EC28E76E311Q26996159-66DA7595-2063-4886-A20C-41B4B5490679Q26998790-586D3E51-652F-4E2E-87A4-D800BBA3D2E9Q27006839-7BD81807-3429-444B-A04B-8265F7C3547AQ27014126-4B0AD232-D6C4-4952-9DD0-FCF077188699Q27313766-0D201E10-D674-4509-803F-AC985377CC15Q27321859-837BC14F-F322-48A4-BEBC-FCD2E12A6201Q27468694-2099513F-78A9-4B92-9917-878E124FA0F6Q27499832-70C305E3-98DA-47F9-959D-DAC5A5DF0EAFQ27683345-A2EC3B2E-BEAC-49FA-A163-3501FCC5056CQ27687755-AE254594-886D-490F-95D2-1CB006F4FBBCQ27852630-67B1687B-6F01-4C7C-AC52-5C5E2C857599Q27852764-C1D76C47-4E05-422F-8F15-274ABBD85C6E
P2860
Integrated genomic characterization of endometrial carcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Integrated genomic characterization of endometrial carcinoma
@ast
Integrated genomic characterization of endometrial carcinoma
@en
Integrated genomic characterization of endometrial carcinoma
@nl
type
label
Integrated genomic characterization of endometrial carcinoma
@ast
Integrated genomic characterization of endometrial carcinoma
@en
Integrated genomic characterization of endometrial carcinoma
@nl
prefLabel
Integrated genomic characterization of endometrial carcinoma
@ast
Integrated genomic characterization of endometrial carcinoma
@en
Integrated genomic characterization of endometrial carcinoma
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Integrated genomic characterization of endometrial carcinoma
@en
P2093
A Gordon Robertson
Andrew D Cherniack
Christina Yau
Christopher C Benz
Douglas A Levine
Gordon B Mills
Itai Pashtan
Peter W Laird
P2860
P2888
P356
10.1038/NATURE12113
P407
P577
2013-05-02T00:00:00Z
P5875
P6179
1004984574